Literature DB >> 11026694

Tolerance of the normal canine brain to epithermal neutron irradiation in the presence of p-boronophenylalanine.

J A Coderre1, P R Gavin, J Capala, R Ma, G M Morris, T M Button, T Aziz, N S Peress.   

Abstract

Twelve normal dogs underwent brain irradiation in a mixed-radiation, mainly epithermal neutron field at the Brookhaven Medical Research Reactor following intravenous infusion of 950 mg of 10B-enriched BPA/kg as its fructose complex. The 5 x 10 cm irradiation aperture was centered over the left hemisphere. For a subgroup of dogs reported previously, we now present more detailed analyses including dose-volume relationships, longer follow-ups, MRIs, and histopathological observations. Peak doses (delivered to 1 cm3 of brain at the depth of maximum thermal neutron flux) ranged from 7.6 Gy (photon-equivalent dose: 11.8 Gy-Eq) to 11.6 Gy (17.5 Gy-Eq). The average dose to the brain ranged from 3.0 Gy (4.5 Gy-Eq) to 8.1 Gy (11.9 Gy-Eq) and to the left hemisphere, 6.6 Gy (10.1 Gy-Eq) to 10.0 Gy (15.0 Gy-Eq). Maximum tolerated 'threshold' doses were 6.7 Gy (9.8 Gy-Eq) to the whole brain and 8.2 Gy (12.3 Gy-Eq) to one hemisphere. The threshold peak brain dose was 9.5 Gy (14.3 Gy-Eq). At doses below threshold, some dogs developed subclinical MRI changes. Above threshold, all dogs developed dose-dependent MRI changes, neurological deficits, and focal brain necrosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11026694     DOI: 10.1023/a:1006419210584

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  33 in total

1.  Epithermal beam development at the BMRR: dosimetric evaluation.

Authors:  S K Saraf; J Kalef-Ezra; R G Fairchild; B H Laster; S Fiarman; E Ramsey
Journal:  Basic Life Sci       Date:  1990

2.  Fast neutron and mixed (neutron/photon) beam teletherapy for grades III and IV astrocytomas.

Authors:  G E Laramore; T W Griffin; A J Gerdes; R G Parker
Journal:  Cancer       Date:  1978-07       Impact factor: 6.860

3.  Effect of dose and infusion time on the delivery of p-boronophenylalanine for neutron capture therapy.

Authors:  D D Joel; J A Coderre; P L Micca; M M Nawrocky
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

4.  Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.

Authors:  J A Coderre; A D Chanana; D D Joel; E H Elowitz; P L Micca; M M Nawrocky; M Chadha; J O Gebbers; M Shady; N S Peress; D N Slatkin
Journal:  Radiat Res       Date:  1998-02       Impact factor: 2.841

5.  Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy.

Authors:  E H Elowitz; R M Bergland; J A Coderre; D D Joel; M Chadha; A D Chanana
Journal:  Neurosurgery       Date:  1998-03       Impact factor: 4.654

Review 6.  Boron neutron capture therapy of brain tumors: past history, current status, and future potential.

Authors:  R F Barth; A H Soloway; R M Brugger
Journal:  Cancer Invest       Date:  1996       Impact factor: 2.176

7.  Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin.

Authors:  H Fukuda; J Hiratsuka; C Honda; T Kobayashi; K Yoshino; H Karashima; J Takahashi; Y Abe; K Kanda; M Ichihashi
Journal:  Radiat Res       Date:  1994-06       Impact factor: 2.841

Review 8.  The radiation biology of boron neutron capture therapy.

Authors:  J A Coderre; G M Morris
Journal:  Radiat Res       Date:  1999-01       Impact factor: 2.841

9.  Methods for radiation dose distribution analysis and treatment planning in boron neutron capture therapy.

Authors:  D W Nigg
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-03-30       Impact factor: 7.038

10.  Response of the central nervous system to boron neutron capture irradiation: evaluation using rat spinal cord model.

Authors:  G M Morris; J A Coderre; J W Hopewell; P L Micca; M M Nawrocky; H B Liu; A Bywaters
Journal:  Radiother Oncol       Date:  1994-09       Impact factor: 6.280

View more
  3 in total

1.  Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden.

Authors:  Jacek Capala; Britta H Stenstam; Kurt Sköld; Per Munck af Rosenschöld; Valerio Giusti; Charlotta Persson; Eva Wallin; Arne Brun; Lars Franzen; Jörgen Carlsson; Leif Salford; Crister Ceberg; Bertil Persson; Luigi Pellettieri; Roger Henriksson
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

2.  Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax.

Authors:  Peng Wang; Haining Zhen; Xinbiao Jiang; Wei Zhang; Xin Cheng; Geng Guo; Xinggang Mao; Xiang Zhang
Journal:  BMC Cancer       Date:  2010-12-02       Impact factor: 4.430

Review 3.  Response of Normal Tissues to Boron Neutron Capture Therapy (BNCT) with 10B-Borocaptate Sodium (BSH) and 10B-Paraboronophenylalanine (BPA).

Authors:  Hiroshi Fukuda
Journal:  Cells       Date:  2021-10-26       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.